Fungal infection drug tested as potential brain tumor fighter
NCT ID NCT04825275
Summary
This small, early-stage study tested whether a common antifungal drug called posaconazole can get into brain tumors at high enough levels to potentially stop cancer cells from growing. Researchers gave the drug to a few adults with a type of aggressive brain cancer before their scheduled surgery. They then used special catheters to measure how much of the drug reached the tumor, hoping to learn if it should be studied further as a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.